Your browser doesn't support javascript.
loading
An alternative signal 3: CD8⁺ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling.
Sanchez, Phillip J; Kedl, Ross M.
Afiliación
  • Sanchez PJ; Integrated Department of Immunology, University of Colorado Denver, National Jewish Health, CO 80206, United States. phillip-sanchez@uiowa.edu
Vaccine ; 30(6): 1154-61, 2012 Feb 01.
Article en En | MEDLINE | ID: mdl-22178730
Type I IFN and IL-12 are well documented to serve as so called "signal 3" cytokines, capable of facilitating CD8(+) T cell proliferation, effector function and memory formation. While their ability to serve in this capacity is well established, to date, no non-cytokine signal 3 mediators have been clearly identified. We have established a vaccine model system in which the primary CD8(+) T cell response is independent of either IL-12 or type I IFN receptors, but dependent on CD27/CD70 interactions. We show here that primary and secondary CD8(+) T cell responses are generated in the combined deficiency of IFN and IL-12 signaling. In contrast, antigen specific CD8(+) T cell responses are compromised in the absence of the TNF receptors CD27 and OX40. These data indicate that CD27/OX40 can serve the central function as signal 3 mediators, independent of IFN or IL-12, for the generation of CD8(+) T cell immune memory.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transducción de Señal / Interferón Tipo I / Miembro 7 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Interleucina-12 / Linfocitos T CD8-positivos / Receptores OX40 / Memoria Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Transducción de Señal / Interferón Tipo I / Miembro 7 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Interleucina-12 / Linfocitos T CD8-positivos / Receptores OX40 / Memoria Inmunológica Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Vaccine Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos